Developing therapeutic monoclonal antibodies at pandemic pace
Sign Up to like & getrecommendations! Published in 2020 at "Nature Biotechnology"
DOI: 10.1038/s41587-020-0512-5
Abstract: The time from discovery to proof-of-concept trials could be reduced to 5–6 months from a traditional timeline of 10–12 months. read more here.
Keywords: pandemic pace; monoclonal antibodies; therapeutic monoclonal; antibodies pandemic ... See more keywords
The challenges with developing therapeutic monoclonal antibodies for pandemic application
Sign Up to like & getrecommendations! Published in 2021 at "Expert Opinion on Drug Discovery"
DOI: 10.1080/17460441.2021.1976141
Abstract: Throughout history, pandemics like the Black Death or the Spanish Flue have periodically wiped out large parts of populations. Today, history repeats itself with the on-going SARSCoV-2 pandemic, which manifests that pandemics still hold the… read more here.
Keywords: challenges developing; therapeutic monoclonal; pandemic application; developing therapeutic ... See more keywords